AstraZeneca PLC (NASDAQ:AZN)
| 59.12 Delayed Data As of Sep 21 |  +0.63 / +1.08%Today’s Change | 46.48 Today|||52-Week Range 60.93 | +18.26% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 58.50 |
| Today’s open | 58.87 |
| Day’s range | 58.63 - 59.51 |
| Volume | 8,696,166 |
| Average volume (3 months) | 9,239,983 |
| Market cap | $172.1B |
Data as of 4:50pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | +137.38% |
| Earnings growth (this year) | +36.51% |
| Earnings growth (next 5 years) | +18.60% |
| Revenue growth (last year) | +13.16% |
| P/E ratio | 41.2 |
| Price/Sales | 4.76 |
| Price/Book | 9.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.04 | +0.06% |
| NVSNovartis | +0.02 | +0.02% |
| ABBVAbbVie | +0.75 | +0.70% |
| NVONovo Nordisk | +2.11 | +2.12% |
Data as of 4:09pm ET, 09/21/2021
Financials
| Next reporting date | November 12, 2021 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $27.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
